SavedAdd your journal

Journals / Yeni Tıp Dergisi / 2009 / Cilt: 26 - Sayı: 3

Gestational diabetes mellitus diagnosis and treatment

Gestasyonel diabetes mellitus tanı ve tedavisi

Feridun KARAKURT
Ayşe ÇARLIOĞLU
Benan KASAPOĞLU
İlknur İnegöl GÜMÜŞ
Pages
134–138
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review we aim to discuss GDM diagnosis, incidence, risks and treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gestational Diabetes Mellitus is defined as glucose intolerance that comes out or is first recognized during pregnancy, and disappears after delivery.
📊
Key Findings & Data:In different studies it’s incidence is reported in between 1-14% and the incidence is increasing.
💡
Conclusion & Impact:In this review we aim to discuss GDM diagnosis, incidence, risks and treatment.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Gestational Diabetes Mellitus is defined as glucose intolerance that comes out or is first recognized during pregnancy, and disappears after delivery. In different studies it’s incidence is reported in between 1-14% and the incidence is increasing. Screening tests are generally recommended in 24th-28th weeks of pregnancy. The 75 or 100 gram OGTT is the diagnostic test. If the blood glucose levels can not be regulated with diet or exercise, insulin treatment is another option. Studies dealing with the use of oral antidiabetics in GDM treatment are challenging. Nowadays the complication rates are very low due to early diagnosis and close chasing. These patients should be followed up after pregnancy for the development of Diabetes Mellitus Type 2. In this review we aim to discuss GDM diagnosis, incidence, risks and treatment.

Özet

Gestasyonel diyabet ilk kez gebelikte ortaya çıkan ya da gebelik sırasında tanı konulan glukoz tolerans bozuklu-ğudur. Farklı toplumlarda %1–14 oranlarında bildirilmek-tedir. Sıklığı giderek artmaktadır. Tarama testleri genel-likle gebeliğin 24–28. haftalarında yapılmaktadır. Tanıda ise 75 ya da 100 gram OGTT kullanılmaktadır. Diyet ve egzersizle kan şekeri düzenlenemeyen hastalarda insülin tedavisine geçilir. Oral antidiyabetiklerin gestasyonel diyabette kullanımı ile ilgili çalışmalar devam etmektedir. Erken tanı ve yakın takiplerle günümüzde komplikasyon oranları son derece azalmıştır. Bu hastaların postpartum dönemde Tip 2 diyabet gelişimi yönünden bilgilendiril-meleri ve takip edilmeleri gerekmektedir.

🔖

Cite This Article

KARAKURT, F., ÇARLIOĞLU, A., KASAPOĞLU, B., GÜMÜŞ, İ. İ. (2009). Gestational diabetes mellitus diagnosis and treatment. Yeni Tıp Dergisi, Cilt: 26 - Sayı: 3, 134–138. https://ajindex.com/articles/338390

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Turok DK, Ratcliffe SD, Baxley AG. Management of gestational diabetes mellitus. Am Fam Physician 2003;68: 1769–72.
  2. Dornhorst A, Paterson CM, Nicholls JS, Wadsworth J, Chiu DC, Elkeles RS, et al. High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med 1992;9: 820–825.
  3. Marquette GP, Klein VR, Niebyl JR. Efficacy of screening for gestational diabetes. Am J Perinatol 1985;2: 7–9.
  4. Kim C, Tabaei BP, Burke R, McEwen LN, Lash RW, Johnson SL, et al. Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health 2006;96: 1643-8.
  5. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of Type 2 diabetes: a systematic review. Diabetes Care 2002;25: 1862-8.
  6. Benjamin F, Wilson SJ, Deutsch S, Seltzer VL, Droesch K, Droesch J. Effect of advancing pregnancy on the glucose tolerance test and on the 50-g oral glucose load screening test for gestational diabetes. Obstet Gynecol 1986;68: 362–65.
  7. Egeland GM, Skjærven R, Irgens LM. Birth characteristics of women who develop gestational diabetes: population based study. BMJ 2000;321: 545–7.
  8. Brody SC, Harris R, Lohr K. Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 2003;101: 380–92. Gestational diabetes mellitus. Diabetes Care 2003;26: 103–5.
  9. Berger H, Crane J, Farine D. Screening for gestational diabetes mellitus. JOGC 2002;24: 894–912.
  10. Jovanovic-Peterson L, Peterson CM, Reed GF, Metzger BE, Mills JL, Knopp RH, et al. Maternal postprandial glucose levels and infant birth weight: the diabetes in early pregnancy study. Am J Obstet Gynecol 1991;164: 103–11.
  11. Cousins L, Dattel BJ, Hollingsworth DR, Zettner A. Glycosylated hemoglobin as a screening test for carbohydrate intolerance in pregnancy. Am J Obstet Gynecol 1984;150: 455–60.
  12. Nasrat HA, Ajabnoor MA, Ardawi MSM. Fructosamine as a screening-test for gestational diabetes mellitus: a reappraisal. Int J Gynaecol Obstet 1990;34: 27–33
  13. Scott DA, Loveman E, McIntyre L, Waugh N. Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol Assess 2002;6: 1–161.
  14. Grandjean H, Sarramon MF, De Mouzon J, Reme JM, Pontonnier G. Detection of gestational diabetes by means of ultrasonic diagnosis of excessive fetal growth. Am J Obstet Gynecol 1980;138: 790–2. O’Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964;13: 278–85. Nat